Quoin Pharmaceuticals Ltd. - American Depositary Shares, each representing thirty-five (35) Ordinary Shares, no par value per share (QNRX)

Q: What does CUSIP 74907L409 represent in this 13F holders report?

CUSIP 74907L409 is the security identifier for QNRX - Quoin Pharmaceuticals Ltd. - American Depositary Shares, each representing thirty-five (35) Ordinary Shares, no par value per share used to aggregate holder disclosures.

Q: How many institutions held QNRX - Quoin Pharmaceuticals Ltd. - American Depositary Shares, each representing thirty-five (35) Ordinary Shares, no par value per share in Q1 2025?

1 institutional investor reported QNRX - Quoin Pharmaceuticals Ltd. - American Depositary Shares, each representing thirty-five (35) Ordinary Shares, no par value per share for Q1 2025. Use the holders table for investor-level position and value details.

CUSIP: 74907L409

Q1 2025 13F Holders as of 31 Mar 2025

Security type / class: Equity / American Depositary Shares, each representing thirty-five (35) Ordinary Shares, no par value per share
Total 13F shares: 108
Total 13F value: $24
Share change: +108
SEC-reported price per share: $0.22
Number of holders: 1
Value change: +$24
Number of buys: 1
Shares outstanding: 4,807,682

Security key

74907L409

Report period

Q1 2025

Institutions

Top holders

QNRX full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2025 Quoin Pharmaceuticals Ltd. SEC filings Quoin Pharmaceuticals Ltd. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 74907L409

Newer quarter: Q3 2025

Recent filing periods:

Q3 2026 Q2 2026 Q1 2026 Q4 2025 Q3 2025

Ownership snapshot

Top reported holders of QNRX - Quoin Pharmaceuticals Ltd. - American Depositary Shares, each representing thirty-five (35) Ordinary Shares, no par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

ARMISTICE CAPITAL, LLC

Disclosed value leader

ARMISTICE CAPITAL, LLC

Comparable rows

3/15

Latest evidence

31 Mar 2025

13D/G 13F 3/4/5 Lead comparable stake: 5% 12 rows are not safely comparable across share classes. 13D/G row: ARMISTICE CAPITAL, LLC Showing 1-6 of 15 holder rows.

Quick read

ARMISTICE CAPITAL, LLC leads the comparable SEC ownership view at 5%.

3 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens ARMISTICE CAPITAL, LLC's linked filing trail.

Comparable ownership Top 3

ARMISTICE CAPITAL, LLC 5%

Denise P. Carter 4.9%

Michael Myers 4.9%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
ARMISTICE CAPITAL, LLC	13D/G 13F Company 13D/G 13F	5% Reported 13D/G · 31 Mar 2025	$7,049,313 1,081,183 shares	$0	31 Mar 2025
Denise P. Carter	13D/G Denise Carter 13D/G	4.9% Reported 13D/G · 27 Jan 2025	$244,202 939,238 shares	+$82,374	27 Jan 2025
Michael Myers	13D/G 13D/G	4.9% Reported 13D/G · 27 Jan 2025	$244,200 939,230 shares	+$82,331	27 Jan 2025
Altium Capital Management LLC	13F Company 13F	— denominator unverified	$183,659 282,249 shares	—	31 Dec 2024
Ikarian Capital, LLC	13F Company 13F	— denominator unverified	$178,942 275,000 shares	—	31 Dec 2024
RENAISSANCE TECHNOLOGIES LLC	13F Company 13F	— denominator unverified	$86,622 133,122 shares	—	31 Dec 2024

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

108

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2025 vs Q2 2026 Across Filers

Q2 2026 holders

Q1 2025 holders

Holder diff

-18

Investor	Q2 2026 Shares	Q1 2025 Shares	Share Diff	Share Chg %	Q2 2026 value	Q1 2025 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend